Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion type Assertion NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_head.
- NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion description "[The poly(ADP-ribose) polymerase inhibitor olaparib has shown antitumour activity in patients with platinum-sensitive, recurrent, high-grade serous ovarian cancer with or without BRCA1 or BRCA2 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_provenance.
- NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion evidence source_evidence_literature NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_provenance.
- NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion SIO_000772 25481791 NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_provenance.
- NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion wasDerivedFrom befree-2016 NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_provenance.
- NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_assertion wasGeneratedBy ECO_0000203 NP1245500.RATHdki1yJBAScQtv6vBGYJVbRx0hs1Kay1Jci180qvvg130_provenance.